冲程(发动机)
医学
生物标志物
内科学
脑损伤
急性中风
病理
心脏病学
生物化学
化学
组织纤溶酶原激活剂
工程类
机械工程
作者
Yongli He,Zhiyou Cai,Yangmei Chen
标识
DOI:10.1080/00207454.2018.1481065
摘要
The S-100β levels are associated with a variety of acute disorders and other chronic diseases, such as head injury, stroke, metastatic melanoma, cardiac surgery, bone fractures, burns and contusions. The serum S-100β levels seem to increase with the volume of tissue damage. Higher serum S-100β levels have been observed after brain damage or stroke. A number of studies have evidenced the clinical value of S-100β in the diagnosis and prognosis of stroke while the S-100β marker is elevated in the peripheral blood during the acute phase of stroke. However, the clinical usefulness of S-100β biomarker in the diagnosis and prognosis of stroke has a limitation due to its low discriminating ability in stroke diagnosis and prognosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI